Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Tübingen, Universität Tübingen, Dissertation, 2017
- Schlagwort
-
Liver--Cancer
Measles vaccine
Histone deacetylase
Tumor ; Onkologie ; Viren ; Epigenetik ; Leberkrebs
- Ereignis
-
Veröffentlichung
- (wo)
-
Tübingen
- (wer)
-
Universitätsbibliothek Tübingen
- (wann)
-
2017
- Urheber
- Beteiligte Personen und Organisationen
-
Lauer, Ulrich
- URN
-
urn:nbn:de:bsz:21-dspace-790589
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ruf, Benjamin
- Lauer, Ulrich
- Universitätsbibliothek Tübingen
Entstanden
- 2017
Ähnliche Objekte (12)
Evaluation of a novel epi-virotherapeutic treatment strategy of pancreatic cancer combining the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Histone deacetylase 6 in cancer
Epi-revolution in rheumatology: the potential of histone deacetylase inhibitors for targeted rheumatoid arthritis intervention
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Key parameters of measles virus production for oncolytic virotherapy
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Dendritic cell development requires histone deacetylase activity
Evaluation of a novel epi-virotherapeutic treatment strategy of pancreatic cancer combining the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Histone deacetylase 6 in cancer
Epi-revolution in rheumatology: the potential of histone deacetylase inhibitors for targeted rheumatoid arthritis intervention
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Key parameters of measles virus production for oncolytic virotherapy
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Dendritic cell development requires histone deacetylase activity
Evaluation of a novel epi-virotherapeutic treatment strategy of pancreatic cancer combining the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Histone deacetylase 6 in cancer
Epi-revolution in rheumatology: the potential of histone deacetylase inhibitors for targeted rheumatoid arthritis intervention
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Key parameters of measles virus production for oncolytic virotherapy
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma